{
  "id": 14875135,
  "title": "Myomo CMO Harry Kovelman sells $20,136 in company stock",
  "url": "https://urgent.news/2026/10/16/myomo-cmo-harry-kovelman-sells-20-136-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T05:15:57.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/myomo-cmo-harry-kovelman-sells-20136-in-company-stock-93CH-4953103"
  },
  "original_language": "en",
  "account": "On September 11, 2026, Harry Kovelman, the Chief Medical Officer at MYOMO, INC. (NASDAQ: MYO), sold 15,844 shares of the company's common stock, according to the company's disclosure filings. The sale totaled $20,136, with each share sold at prices between $1.25 and $1.29. After completing these transactions, Mr. Kovelman retained ownership of 89,889 shares of MYO common stock. This amendment to the filing corrects an error in the number of shares sold and the number of shares beneficially owned. The insider sale took place as MYO stock traded at $1.30, marking a 9% decline over the previous week. Based on InvestingPro analysis, the stock currently appears undervalued compared to its Fair Value and is listed on the platform’s Most Undervalued stocks. For those interested in a deeper analysis, a Pro Research Report is available for MYO and over 1,400 US equities. Meanwhile, Myomo Inc. reported improved financial results for its second quarter, with revenue increasing by 21% to $11.7 million, exceeding Wall Street expectations. The company narrowed its net loss to $0.09 per share, down from the expected loss of $0.10 per share. Moreover, the gross margin widened, signaling enhanced operational efficiency. These positive developments have led to a favorable outlook for the company's full-year sales, prompting a positive response from investors. This report was generated with AI assistance and reviewed by an editor.",
  "summary": null,
  "key_points": [
    "CMO Harry Kovelman sold 15,844 MYO shares for $20,136",
    "Sale price per share ranged from $1.25 to $1.29",
    "Post-sale, Kovelman retains 89,889 MYO shares"
  ],
  "editors_take": "The executive's decision to liquidate a small portion of his holdings occurs despite improved quarterly margins and revenue growth that exceeded Wall Street expectations.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}